ISSN: 2469-2778 HTIJ

Hematology & Transfusion International Journal
Case Report
Volume 3 Issue 3 - 2016
Melanonychia Blue Lunula: Result of Hydroxyurea Treatment
Ülkü Ergene and Can Özlü*
Department of Hematology, Bozyaka Education and Research Hospital, Turkey
Received: July 08, 2016 | Published: December 30, 2016
*Corresponding author: Can Özlü, Department of Hematology, Bozyaka Education and Research Hospital, İzmir, Turkey, Tel: +232-2505050; Email:
Citation: Ergene U, Özlü C (2016) Melanonychia Blue Lunula: Result of Hydroxyurea Treatment. Hematol Transfus Int J 3(3): 00069. DOI: 10.15406/htij.2016.03.00069

Abstract

Hydroxycarbamide is used in the treatment of Essential Thrombocytosis (ET) and other myeloproliferative disorders [1]. Melanonychia is one of the cutaneous abnormalities including nail changes that could develop with long-term treatment with hydroxycarbamide [2]. Women have a tendency to melanonychia secondary to hydroxycarbamide usage [3]

Keywords: Hydroxy urea; Melanonychia; hydroxycarbamide; Essential Thrombocytosis

Case study

Case 1: 49-year-old male patient diagnosed JAK -2V617F positive Polycythemia Vera. After 11 months of treatment with 1000mg/day Hydroxyurea (HU), blue lunula and longitudinal melanonychia was seen in fingers and face (Figure 1).

Case 2: 63-year-old female patient diagnosed JAK-2V617F positive ET. After use of 1500 mg/day HU in 4 months; blue-black pigment changes in bilaterally fingernails-blue lunula transverse melanonychia occured. (Figure2). Patients were done to rule out other factors that cause melanonychia. After discontinued HU treatment, male patient’s melanonichia findings regressed within 3 months, for female patients it was 4 months. Melanonychia induced by drugs can be caused by the activation of nail matrix melanocytes. It can present longitudinal, transverse or diffuse pigmentation in the nail plate [4]. HU can rarely cause transverse and longitudinal melanonychia of both finger and toe nails. The occurrence of such a rare adverse effect with a common drug has prompted this report.

Figure 1: Melanonychia of the upper extremity hand-nails and face findings.
Figure 2: Blue lunula in nails and face findings.

References

  1. Boyd AS, Neldner KH (1991) Hydroxyurea therapy. J Am Acad Dermatol 25(3): 518-524.
  2. Vomvouras S, Pakula AS, Shaw JM (1991) Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol 24(6 Pt 1): 1016-1017.
  3. Neynaber S, Wolff H, Plewig G, Wienecke R (2004) Longitudinal melanonychia induced by hydroxyurea therapy. J Dtsch Dermatol Ges 2(7): 588-591.
  4. Piraccini BM, Iorizzo M (2007) Drug Reactions Affecting the Nait Unit: Diagnosis and Management. Dermatol Clin 25(2): 215-221.
Scholar Awards

At MedCrave we believe that knowledge should be shared. We also believe that   Read more...

Paper of the Year

In regard to the novelty and excellence of the manuscript MedCrave Group (MCG)   Read more...

Financial Support

MedCrave loves to recognize all the outstanding services delivered in the realms   Read more...

Sponsors

MedCrave accelerates the advancement of scientific research by convening   Read more...

MedCrave Reprints

MedCrave Group is ardent to provide article reprints at an instant affordable Read more...

© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy